We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

212 hedge funds and large institutions have $320M invested in Immunogen Inc in 2019 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 32

26% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $10.3M

19% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 54

6% more funds holding

Funds holding: 200212 (+12)

46% less capital invested

Capital invested by funds: $589M → $320M (-$269M)

Holders
212
Holders Change
+12
Holders Change %
+6%
% of All Funds
4.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
64
Reduced
54
Closed
32
Calls
$13.1M
Puts
$10.3M
Net Calls
+$2.72M
Net Calls Change
-$12.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
26
Candriam SCA
Luxembourg
$3.13M +$579K +133,582 +13%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.71M -$324K -74,839 -7%
Charles Schwab
28
Charles Schwab
California
$2.26M -$39.1K -9,016 -1%
Rafferty Asset Management
29
Rafferty Asset Management
New York
$1.96M +$3.13M +722,765 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.69M +$72.4K +16,713 +3%
RJA
31
Raymond James & Associates
Florida
$1.68M +$103K +23,774 +4%
Two Sigma Investments
32
Two Sigma Investments
New York
$1.67M -$2.13M -491,899 -44%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.31M +$2.1M +483,839 New
Man Group
34
Man Group
United Kingdom
$1.21M -$15.6K -3,600 -0.8%
ARTA
35
A.R.T. Advisors
New York
$1.21M +$1.93M +445,118 New
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$1.17M +$768K +177,243 +70%
Norges Bank
37
Norges Bank
Norway
$1.16M
Two Sigma Advisers
38
Two Sigma Advisers
New York
$1.05M +$778K +179,700 +87%
AA
39
ALPS Advisors
Colorado
$976K +$67.4K +15,550 +5%
Macquarie Group
40
Macquarie Group
Australia
$949K -$1.3M -300,000 -46%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$946K -$152K -35,086 -9%
Citadel Advisors
42
Citadel Advisors
Florida
$853K -$9.99M -2,305,912 -88%
Squarepoint
43
Squarepoint
New York
$819K +$56.9K +13,125 +5%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$784K +$3.18K +735 +0.3%
TCIM
45
TIAA CREF Investment Management
New York
$783K -$1.21M -280,205 -49%
Voloridge Investment Management
46
Voloridge Investment Management
Florida
$743K +$1.19M +274,316 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$736K +$35.5K +8,200 +3%
AllianceBernstein
48
AllianceBernstein
Tennessee
$601K -$502K -115,780 -34%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$600K -$5.88K -1,358 -0.6%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$562K +$43.3K +10,000 +22%

IMGN Hedge Fund Activity: Q1 2019 in Review

212 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2019, worth a combined $320M — down 46% from $589M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMGN positions and 32 closed out — a net gain of 12 holders — while 64 added to existing stakes and 54 trimmed.

The largest buyer was State Street, adding an estimated $19.7M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.

  • 212 institutional investors held Immunogen Inc (IMGN) as of Q1 2019, up from 200 in Q4 2018.
  • Funds reported $320M of Immunogen Inc stock for Q1 2019, down 46% quarter-over-quarter.
  • 44 funds opened new Immunogen Inc positions in Q1 2019 and 32 closed out, a net change of +12 holders.
  • The largest Immunogen Inc buyer in Q1 2019 was State Street, an estimated $19.7M added.
  • The largest Immunogen Inc seller in Q1 2019 was Fidelity Investments, an estimated $20.5M sold.

Based on aggregated 13F filings for Q1 2019.